AptarGroup, Inc. logo

AptarGroup, Inc. (ATR)

Market Closed
3 Jul, 20:00
NYSE NYSE
$
161. 04
+0.72
+0.45%
$
10.64B Market Cap
31.31 P/E Ratio
1.8% Div Yield
235,100 Volume
4.69 Eps
$ 160.32
Previous Close
Day Range
159.82 161.36
Year Range
130.85 178.03
Want to track ATR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 17 days
AptarGroup, Inc. (ATR) Q1 2025 Earnings Call Transcript

AptarGroup, Inc. (ATR) Q1 2025 Earnings Call Transcript

AptarGroup, Inc. (NYSE:ATR ) Q1 2025 Earnings Conference Call May 2, 2025 9:00 AM ET Company Participants Mary Skafidas - Senior Vice President, Investor Relations & Communications Stephan Tanda - President & Chief Executive Officer Vanessa Kanu - Executive Vice President & Chief Financial Officer Conference Call Participants George Staphos - Bank of America Ghansham Panjabi - Baird Matt Roberts - Raymond James Daniel Rizzo - Jefferies Matt Larew - William Blair Gabe Hajde - Wells Fargo Operator Ladies and gentlemen, thank you for standing by. Welcome to Aptar's 2025 First Quarter Results Conference Call.

Seekingalpha | 2 months ago
AptarGroup (ATR) Q1 Earnings Top Estimates

AptarGroup (ATR) Q1 Earnings Top Estimates

AptarGroup (ATR) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.26 per share a year ago.

Zacks | 2 months ago
Aptar Reports First Quarter 2025 Results

Aptar Reports First Quarter 2025 Results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports First Quarter 2025 Results.

Businesswire | 2 months ago
Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025

Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025

Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignancies Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignancies

Globenewswire | 2 months ago
AptarGroup (ATR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

AptarGroup (ATR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

AptarGroup (ATR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 2 months ago
AptarGroup: Strong Pharma And Closure Growth To Offset Beauty Headwinds

AptarGroup: Strong Pharma And Closure Growth To Offset Beauty Headwinds

AptarGroup is poised for growth in its Pharma and Closure segments, but challenges are expected in the Beauty segment. The prescription drug business is expected to drive revenue growth in the Pharma segment. Margin expansion anticipated from operational leverage, cost management, and premium product mix.

Seekingalpha | 2 months ago
Technip Energies awarded major contract for Blue Point Number One ATR, the world's largest low-carbon ammonia production facility

Technip Energies awarded major contract for Blue Point Number One ATR, the world's largest low-carbon ammonia production facility

Technip Energies (PARIS:TE) has been awarded a major( 1) contract by Blue Point Number One, a joint venture between CF Industries, JERA, and MITSUI & CO, for the Blue Point Number One ATR Project in Donaldsonville, Louisiana. This project aims to deliver the world's largest low-carbon ammonia plant with a capacity of approximately 1.4 million metric tons per year.

Globenewswire | 2 months ago
AptarGroup Earnings Surpass Estimates in Q4, Increase 27% Y/Y

AptarGroup Earnings Surpass Estimates in Q4, Increase 27% Y/Y

ATR's Q4 top line gains from improved performances of the Pharma and Closures segments.

Zacks | 4 months ago
International Markets and AptarGroup (ATR): A Deep Dive for Investors

International Markets and AptarGroup (ATR): A Deep Dive for Investors

Explore AptarGroup's (ATR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Zacks | 4 months ago
AptarGroup, Inc. (ATR) Q4 2024 Earnings Call Transcript

AptarGroup, Inc. (ATR) Q4 2024 Earnings Call Transcript

AptarGroup, Inc. (NYSE:ATR ) Q4 2024 Earnings Conference Call February 7, 2025 9:00 AM ET Company Participants Mary Skafidas - Senior Vice President, Investor Relations & Communications Stephan Tanda - President & Chief Executive Officer Vanessa Kanu - Executive Vice President & Chief Financial Officer Conference Call Participants George Staphos - Bank of America Ghansham Panjabi - Baird Matt Roberts - Raymond James Daniel Rizzo - Jefferies Matt Larew - William Blair Gabe Hajde - Wells Fargo Operator Ladies and gentlemen, thank you for standing by. Welcome to Aptar's 2024 Fourth Quarter and Annual Results Conference Call.

Seekingalpha | 4 months ago
AptarGroup (ATR) Tops Q4 Earnings Estimates

AptarGroup (ATR) Tops Q4 Earnings Estimates

AptarGroup (ATR) came out with quarterly earnings of $1.52 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.21 per share a year ago.

Zacks | 4 months ago
Aptar Reports Fourth Quarter and Annual 2024 Results

Aptar Reports Fourth Quarter and Annual 2024 Results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Fourth Quarter and Annual 2024 Results.

Businesswire | 4 months ago
Loading...
Load More